Quest Partners LLC Celldex Therapeutics, Inc. Transaction History
Quest Partners LLC
- $737 Billion
- Q2 2024
A detailed history of Quest Partners LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 7,383 shares of CLDX stock, worth $226,288. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,383
Previous 504
1364.88%
Holding current value
$226,288
Previous $21.2 Million
1191.76%
% of portfolio
0.04%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.5MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$248 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$115 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$104 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$102 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.43B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...